Please try another search
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections. It offers revyve, an antimicrobial wound gel; and shampoos, shampoo bars, and scalp detoxifiers under the DermaKB brand. The company is also developing coactiv+ Antimicrobial Surgical Hydrogel for use in surgical/acute wounds; coactiv+ Antimicrobial Wound Rinse for use in acute and chronic wounds; coactiv+ Antimicrobial Wound Gel Spray for use in acute, chronic wounds, and first and second degree burns; and DispersinB Hydrogel for prosthetic joint infection. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
Name | Age | Since | Title |
---|---|---|---|
Georges E. Morin | - | 2020 | Independent Director |
Philip R. Renaud | - | 2010 | Vice Chairman |
Marc Edwards | - | 2016 | President, CEO & Director |
Rashieda Gluck | - | 2018 | Member of Scientific Advisory Board |
Gordon Guay | - | 2018 | Chairman of Scientific Advisory Board |
Robert B. Huizinga | 58 | 2018 | Executive Chairman & Member of Scientific Advisory Board |
John Coleman | - | 2023 | Director |
Gregory S. Schultz | 74 | 2022 | Chief Scientific Officer & Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review